BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lafoz E, Ruart M, Anton A, Oncins A, Hernández-Gea V. The Endothelium as a Driver of Liver Fibrosis and Regeneration. Cells 2020;9:E929. [PMID: 32290100 DOI: 10.3390/cells9040929] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Ma Y, Hu L, Tang J, Guo W, Feng Y, Liu Y, Tang F. Three-Dimensional Cell Co-Culture Liver Models and Their Applications in Pharmaceutical Research. IJMS 2023;24:6248. [DOI: 10.3390/ijms24076248] [Reference Citation Analysis]
2 Lei W, Jia L, Wang Z, Liang Z, Aizhen Z, Liu Y, Tian Y, Zhao L, Chen Y, Shi G, Yang Z, Yang Y, Xu X. CC chemokines family in fibrosis and aging: From mechanisms to therapy. Ageing Res Rev 2023;87:101900. [PMID: 36871782 DOI: 10.1016/j.arr.2023.101900] [Reference Citation Analysis]
3 Jiang T, Wu X, Zhou H, Hu Y, Cao J. Pathological Changes in Hepatic Sinusoidal Endothelial Cells in Schistosoma japonicum-Infected Mice. Trop Med Infect Dis 2023;8. [PMID: 36828540 DOI: 10.3390/tropicalmed8020124] [Reference Citation Analysis]
4 Qiu L, Kong B, Kong T, Wang H. Recent advances in liver‐on‐chips: Design, fabrication, and applications. Smart Medicine 2023. [DOI: 10.1002/smmd.20220010] [Reference Citation Analysis]
5 Kasztelan-Szczerbinska B, Rycyk-Bojarzynska A, Szczerbinska A, Cichoz-Lach H. Selected Aspects of the Intricate Background of Immune-Related Cholangiopathies-A Critical Overview. Nutrients 2023;15. [PMID: 36771465 DOI: 10.3390/nu15030760] [Reference Citation Analysis]
6 Ezhilarasan D, Najimi M. Intercellular communication among liver cells in the perisinusoidal space of the injured liver: Pathophysiology and therapeutic directions. J Cell Physiol 2023;238:70-81. [PMID: 36409708 DOI: 10.1002/jcp.30915] [Reference Citation Analysis]
7 Zhao X, Xue X, Cui Z, Kwame Amevor F, Wan Y, Fu K, Wang C, Peng C, Li Y. microRNAs-based diagnostic and therapeutic applications in liver fibrosis. Wiley Interdiscip Rev RNA 2022;:e1773. [PMID: 36585388 DOI: 10.1002/wrna.1773] [Reference Citation Analysis]
8 Meng Y, Zhao T, Zhang Z, Zhang D. The role of hepatic microenvironment in hepatic fibrosis development. Ann Med 2022;54:2830-44. [PMID: 36399108 DOI: 10.1080/07853890.2022.2132418] [Reference Citation Analysis]
9 Lebedeva EI. Morphometric parameters of sinusoidal capillaries, interlobular veins and interlobular arteries at different stages of experimental liver fibrosis. Žurnal anatomii i gistopatologii 2022;11:32-38. [DOI: 10.18499/2225-7357-2022-11-3-32-38] [Reference Citation Analysis]
10 Lee S, Baek S, Lee Y, Kim T, Yim J, Son J, Kim H, Kang K, Kim JH, Rhee MH, Park S, Choi S, Park J. Ginsenoside Rg3-enriched Korean red ginseng extract attenuates Non-Alcoholic Fatty Liver Disease by way of suppressed VCAM-1 expression in liver sinusoidal endothelium. Journal of Ginseng Research 2022. [DOI: 10.1016/j.jgr.2022.10.005] [Reference Citation Analysis]
11 Ali N, Ferrao K, Mehta KJ. Liver Iron Loading in Alcohol-Associated Liver Disease. The American Journal of Pathology 2022. [DOI: 10.1016/j.ajpath.2022.08.010] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Soares GA, Pereira GM, Romualdo GR, Biasotti GGA, Stoppa EG, Bakuzis AF, Baffa O, Barbisan LF, Miranda JRA. Biodistribution Profile of Magnetic Nanoparticles in Cirrhosis-Associated Hepatocarcinogenesis in Rats by AC Biosusceptometry. Pharmaceutics 2022;14:1907. [DOI: 10.3390/pharmaceutics14091907] [Reference Citation Analysis]
13 Albadawy R, Hasanin AH, Agwa SHA, Hamady S, Aboul-Ela YM, Raafat MH, Kamar SS, Othman M, Yahia YA, Matboli M. Rosavin Ameliorates Hepatic Inflammation and Fibrosis in the NASH Rat Model via Targeting Hepatic Cell Death. Int J Mol Sci 2022;23:10148. [PMID: 36077546 DOI: 10.3390/ijms231710148] [Reference Citation Analysis]
14 Li R, Bhandari S, Martinez-zubiaurre I, Bruun J, Urbarova I, Smedsrød B, Simón-santamaría J, Sørensen KK. Changes in the proteome and secretome of rat liver sinusoidal endothelial cells during early primary culture and effects of dexamethasone. PLoS ONE 2022;17:e0273843. [DOI: 10.1371/journal.pone.0273843] [Reference Citation Analysis]
15 Harris EN. Will inhibition of cellular crosstalk resolve liver fibrosis? Hepatology 2022;76:558-60. [PMID: 35080050 DOI: 10.1002/hep.32361] [Reference Citation Analysis]
16 Lin Y, Dong MQ, Liu ZM, Xu M, Huang ZH, Liu HJ, Gao Y, Zhou WJ. A strategy of vascular-targeted therapy for liver fibrosis. Hepatology 2022;76:660-75. [PMID: 34940991 DOI: 10.1002/hep.32299] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
17 Nasiri-Ansari N, Androutsakos T, Flessa CM, Kyrou I, Siasos G, Randeva HS, Kassi E, Papavassiliou AG. Endothelial Cell Dysfunction and Nonalcoholic Fatty Liver Disease (NAFLD): A Concise Review. Cells 2022;11:2511. [PMID: 36010588 DOI: 10.3390/cells11162511] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Weiskirchen R. Special Issue on “Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis II”. Cells 2022;11:2403. [DOI: 10.3390/cells11152403] [Reference Citation Analysis]
19 Du W, Wang L. The Crosstalk Between Liver Sinusoidal Endothelial Cells and Hepatic Microenvironment in NASH Related Liver Fibrosis. Front Immunol 2022;13:936196. [DOI: 10.3389/fimmu.2022.936196] [Reference Citation Analysis]
20 Li H. Intercellular crosstalk of liver sinusoidal endothelial cells in liver fibrosis, cirrhosis and hepatocellular carcinoma. Dig Liver Dis 2022;54:598-613. [PMID: 34344577 DOI: 10.1016/j.dld.2021.07.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
21 Garbuzenko DV. Pathophysiological mechanisms of hepatic stellate cells activation in liver fibrosis . World J Clin Cases 2022; 10(12): 3662-3676 [DOI: 10.12998/wjcc.v10.i12.3662] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Abdelghffar EA, Obaid WA, Alamoudi MO, Mohammedsaleh ZM, Annaz H, Abdelfattah MA, Sobeh M. Thymus fontanesii attenuates CCl4-induced oxidative stress and inflammation in mild liver fibrosis. Biomedicine & Pharmacotherapy 2022;148:112738. [DOI: 10.1016/j.biopha.2022.112738] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Raggi C, Selleri S, M'callum M, Paganelli M. Generation of Complex Syngeneic Liver Organoids from Induced Pluripotent Stem Cells to Model Human Liver Pathophysiology. Current Protocols 2022;2. [DOI: 10.1002/cpz1.389] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Wilson SE. Fibrosis Is a Basement Membrane-Related Disease in the Cornea: Injury and Defective Regeneration of Basement Membranes May Underlie Fibrosis in Other Organs. Cells 2022;11:309. [DOI: 10.3390/cells11020309] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
25 Wan Y, Li X, Slevin E, Harrison K, Li T, Zhang Y, Klaunig JE, Wu C, Shetty AK, Dong XC, Meng F. Endothelial dysfunction in pathological processes of chronic liver disease during aging. FASEB J 2022;36:e22125. [PMID: 34958687 DOI: 10.1096/fj.202101426R] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
26 Migdał M, Tralle E, Nahia KA, Bugajski Ł, Kędzierska KZ, Garbicz F, Piwocka K, Winata CL, Pawlak M. Multi-omics analyses of early liver injury reveals cell-type-specific transcriptional and epigenomic shift. BMC Genomics 2021;22. [DOI: 10.1186/s12864-021-08173-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
27 Zhang C, Yang M. Molecular targets regulating endoplasmic reticulum-mitochondria crosstalk for NAFLD treatment. Exploration of Medicine. [DOI: 10.37349/emed.2021.00066] [Reference Citation Analysis]
28 Zhang J, Liu Q, He J, Li Y. Novel Therapeutic Targets in Liver Fibrosis. Front Mol Biosci 2021;8:766855. [PMID: 34805276 DOI: 10.3389/fmolb.2021.766855] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
29 Gomez-Salinero JM, Itkin T, Rafii S. Developmental angiocrine diversification of endothelial cells for organotypic regeneration. Dev Cell 2021;56:3042-51. [PMID: 34813766 DOI: 10.1016/j.devcel.2021.10.020] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
30 Cao JL, Yan JB, Wu JT, Chen ZY. Research progress of sinusoidal endothelial cells in nonalcoholic fatty liver disease. Shijie Huaren Xiaohua Zazhi 2021; 29(21): 1254-1260 [DOI: 10.11569/wcjd.v29.i21.1254] [Reference Citation Analysis]
31 Campreciós G, Ruart M, Anton A, Suárez-Herrera N, Montironi C, Martínez C, Jiménez N, Lafoz E, García-Calderó H, Vilaseca M, Magaz M, Coll M, Graupera I, Friedman SL, García-Pagán JC, Hernández-Gea V. Spermidine Supplementation Protects the Liver Endothelium from Liver Damage in Mice. Nutrients 2021;13:3700. [PMID: 34835956 DOI: 10.3390/nu13113700] [Reference Citation Analysis]
32 Koch PS, Sandorski K, Heil J, Schmid CD, Kürschner SW, Hoffmann J, Winkler M, Staniczek T, de la Torre C, Sticht C, Schledzewski K, Taketo MM, Trogisch FA, Heineke J, Géraud C, Goerdt S, Olsavszky V. Imbalanced Activation of Wnt-/β-Catenin-Signaling in Liver Endothelium Alters Normal Sinusoidal Differentiation. Front Physiol 2021;12:722394. [PMID: 34658910 DOI: 10.3389/fphys.2021.722394] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
33 Manenti A, Roncati L, Manco G, Farinetti A, Mattioli AV. To the Editor: Pathophysiology of Splenic Arteriovenous Fistula. Ann Vasc Surg 2021:S0890-5096(21)00692-0. [PMID: 34648858 DOI: 10.1016/j.avsg.2021.09.018] [Reference Citation Analysis]
34 Yang F, Li H, Li Y, Hao Y, Wang C, Jia P, Chen X, Ma S, Xiao Z. Crosstalk between hepatic stellate cells and surrounding cells in hepatic fibrosis. Int Immunopharmacol 2021;99:108051. [PMID: 34426110 DOI: 10.1016/j.intimp.2021.108051] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
35 Wegrzyniak O, Rosestedt M, Eriksson O. Recent Progress in the Molecular Imaging of Nonalcoholic Fatty Liver Disease. Int J Mol Sci 2021;22:7348. [PMID: 34298967 DOI: 10.3390/ijms22147348] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
36 Loomba R, Friedman SL, Shulman GI. Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell 2021;184:2537-64. [PMID: 33989548 DOI: 10.1016/j.cell.2021.04.015] [Cited by in Crossref: 219] [Cited by in F6Publishing: 255] [Article Influence: 109.5] [Reference Citation Analysis]
37 Cheng QN, Yang X, Wu JF, Ai WB, Ni YR. Interaction of non‑parenchymal hepatocytes in the process of hepatic fibrosis (Review). Mol Med Rep 2021;23:364. [PMID: 33760176 DOI: 10.3892/mmr.2021.12003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
38 Ma H, Liu X, Zhang M, Niu J. Liver sinusoidal endothelial cells are implicated in multiple fibrotic mechanisms. Mol Biol Rep 2021;48:2803-15. [PMID: 33730288 DOI: 10.1007/s11033-021-06269-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
39 Li H. Angiogenesis in the progression from liver fibrosis to cirrhosis and hepatocelluar carcinoma. Expert Rev Gastroenterol Hepatol 2021;15:217-33. [PMID: 33131349 DOI: 10.1080/17474124.2021.1842732] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
40 Berthier A, Johanns M, Zummo FP, Lefebvre P, Staels B. PPARs in liver physiology. Biochim Biophys Acta Mol Basis Dis 2021;1867:166097. [PMID: 33524529 DOI: 10.1016/j.bbadis.2021.166097] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
41 Lambruschini C, Demori I, El Rashed Z, Rovegno L, Canessa E, Cortese K, Grasselli E, Moni L. Synthesis, Photoisomerization, Antioxidant Activity, and Lipid-Lowering Effect of Ferulic Acid and Feruloyl Amides. Molecules 2020;26:E89. [PMID: 33379170 DOI: 10.3390/molecules26010089] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
42 Li Z, Wang F, Liang B, Su Y, Sun S, Xia S, Shao J, Zhang Z, Hong M, Zhang F, Zheng S. Methionine metabolism in chronic liver diseases: an update on molecular mechanism and therapeutic implication. Signal Transduct Target Ther 2020;5:280. [PMID: 33273451 DOI: 10.1038/s41392-020-00349-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
43 Pan X, Ma X, Jiang Y, Wen J, Yang L, Chen D, Cao X, Peng C. A Comprehensive Review of Natural Products against Liver Fibrosis: Flavonoids, Quinones, Lignans, Phenols, and Acids. Evid Based Complement Alternat Med 2020;2020:7171498. [PMID: 33082829 DOI: 10.1155/2020/7171498] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
44 Jia Y, Shu X, Yang X, Sun H, Cao H, Zhang K, Xu Q, Li G, Yang Y. Enhanced therapeutic effects of umbilical cord mesenchymal stem cells after prolonged treatment for HBV-related liver failure and liver cirrhosis. Stem Cell Res Ther. 2020;11:277. [PMID: 32650827 DOI: 10.1186/s13287-020-01787-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]